We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Baxter International
BAX
$14.4B
| $27.3M | 0.06% |
424,447
-148,400
| -26% | -$10.8M |
|
327
Ameriprise Financial
AMP
$49.1B
| $27.2M | 0.06% |
114,468
-1,300
| -1% | -$348K |
|
328
Keurig Dr Pepper
KDP
$42.3B
| $27.2M | 0.06% |
+768,200
| New | +$27.9M |
|
329
Mettler-Toledo International
MTD
$28.8B
| $27.2M | 0.06% |
23,657
-300
| -1% | -$377K |
|
330
Travelers Companies
TRV
$78.8B
| $27M | 0.06% |
+159,913
| New | +$27.8M |
|
|
NVEI
331
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $26.6M | 0.06% |
734,512
-117,267
| -14% | -$6.11M |
|
|
BNY
332
Bank of New York Mellon
BNY
$107B
| $26.4M | 0.06% |
634,016
-177,865
| -22% | -$7.92M |
|
333
NET Power
NPWR
$136M
| $26.4M | 0.06% |
2,700,000
| – | – |
|
334
Monolithic Power Systems
MPWR
$66.5B
| $26.3M | 0.06% |
68,585
-19,500
| -22% | -$8.24M |
|
|
ZT
335
DELISTED
Zimmer Energy Transition Acquisition Corp. Class A Common Stock
ZT
| $26.2M | 0.06% |
2,700,000
| – | – |
|
336
UDR
UDR
$12.3B
| $26.2M | 0.06% |
568,754
-80,600
| -12% | -$4.06M |
|
337
Tyson Foods
TSN
$20.5B
| $26.1M | 0.06% |
303,655
-1,700
| -0.6% | -$152K |
|
|
ACRO
338
DELISTED
Acropolis Infrastructure Acquisition Corp
ACRO
| $26.1M | 0.06% |
2,700,000
| – | – |
|
|
TRTL
339
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
| $26.1M | 0.06% |
2,700,000
| – | – |
|
340
AvalonBay Communities
AVB
$26.9B
| $26.1M | 0.06% |
134,194
+22,514
| +20% | +$4.88M |
|
|
AMK
341
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $26M | 0.06% |
1,384,742
+37,449
| +3% | +$749K |
|
342
Northern Oil and Gas
NOG
$2.22B
| $25.8M | 0.06% |
1,022,697
+22,697
| +2% | +$659K |
|
343
Oneok
OKE
$54.9B
| $25.8M | 0.06% |
465,100
-600
| -0.1% | -$38.9K |
|
344
Ross Stores
ROST
$80.8B
| $25.7M | 0.06% |
365,986
-3,000
| -0.8% | -$267K |
|
345
Pool Corp
POOL
$7.34B
| $25.7M | 0.06% |
73,152
+30,800
| +73% | +$12.2M |
|
|
CTXS
346
DELISTED
Citrix Systems Inc
CTXS
| $25.6M | 0.06% |
263,919
+239,731
| +991% | +$23.9M |
|
347
Albemarle
ALB
$14.3B
| $25.5M | 0.06% |
121,979
+49,800
| +69% | +$11.1M |
|
348
Vale
VALE
$63.2B
| $25.5M | 0.06% |
+1,740,000
| New | +$29.7M |
|
349
Idexx Laboratories
IDXX
$47B
| $25.4M | 0.06% |
72,501
-16,000
| -18% | -$6.52M |
|
350
Marvell Technology
MRVL
$198B
| $25.3M | 0.06% |
582,006
+327,500
| +129% | +$18.6M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.